SCHEMBL6654601

SCHEMBL6654601

CCOC(=O)C1CN(C(=O)OC(C)(C)C)CCN1C(=O)C1CCN(C(=O)OCc2ccccc2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.52
NPC1 O15118 2/20 0.52
RAB9A P51151 2/20 0.52
HTT P42858 2/20 0.51
CYP2C19 P33261 1/20 0.50
STS P08842 1/20 0.48
PARP1 P09874 1/20 0.47
LMNA P02545 2/20 0.46
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
GPR119 Q8TDV5 2/20 0.46
CCR6 P51684 1/20 0.46
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
PDK1 Q15118 1/20 0.44
PDK2 Q15119 1/20 0.44
PDK3 Q15120 1/20 0.44
PDK4 Q16654 1/20 0.44
JAK2 O60674 1/20 0.44
JAK1 P23458 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4841744 0.89 PDK1 (0.52) PARP1LMNAKDM4EGPR119MEN1
SCHEMBL6335353 0.89 PARP1 (0.54) SMN1; SMN2NPC1RAB9AHTTCYP2C19
SCHEMBL29701086 0.87 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9AHTTCYP2C19
SCHEMBL3863383 0.87 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9AHTTCYP2C19
SCHEMBL3863378 0.87 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9AHTTCYP2C19
SCHEMBL6981012 0.84 SMN1; SMN2 (0.65) SMN1; SMN2NPC1RAB9AHTTCYP2C19
SCHEMBL1939593 0.84 SMN1; SMN2 (0.65) SMN1; SMN2NPC1RAB9AHTTCYP2C19
SCHEMBL4041583 0.84 HPGD (0.44) HTTKDM4EALDH1A1MEN1KMT2A
SCHEMBL6180319 0.83 SMN1; SMN2 (0.61) SMN1; SMN2NPC1RAB9AHTTCYP2C19
SCHEMBL30706072 0.83 SMN1; SMN2 (0.61) SMN1; SMN2NPC1RAB9AHTTCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1436291-A2 INDOLIZINES AS KINASE PROTEIN INHIBITORS Aventis Pharma S.A. (FR) 2004-07-14 EP disclosed
WO-2003024967-A2 INDOLIZINES AS KINASE PROTEIN INHIBITORS AVENTIS PHARMA S.A. (FR) 2003-03-27 WO disclosed